Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bridgen

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Biochimica Et Biophysica Acta|April 14, 1976
Isolation, characterization and partial sequence of cyanogen bromide fragments and thiol peptides from pig kidney D-amino-acid oxidaseS Ronchi, L Minchiotti, B Curti, et al.
Journal of Clinical Microbiology|January 1, 1978
Production of human lymphoblastoid interferon by Namalva cellsK C Zoon, C E Buckler, P J Bridgen, et al.
European Journal of Biochemistry|July 1, 1980
D-glyceraldehyde-3-phosphate dehydrogenase. Complete amino-acid sequence of the enzyme from Bacillus stearothermophilusJ E Walker, A F Carne, M J Runswick, et al.
Journal of Bacteriology|September 1, 1972
Amino Acid Sequence Around the Catalytic Site in Glyceraldehyde-3-Phosphate Dehydrogenase from Bacillus stearothermophilusJ Bridgen, J I Harris, P W McDonald, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1979
Purification and partial characterization of human lymphoblast interferonK C Zoon, M E Smith, P J Bridgen, et al.
Science (New York, N.Y.)|February 1, 1980
Amino terminal sequence of the major component of human lymphoblastoid interferonK C Zoon, M E Smith, P J Bridgen, et al.
The Journal of Biological Chemistry|October 10, 1977
Human lymphoblastoid interferon. Large scale production and partial purificationP J Bridgen, C B Anfinsen, L Corley, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1979
Large-scale production and concentration of human lymphoid interferonF Klein, R T Ricketts, W I Jones, et al.
Nature Communications|October 13, 2022
Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in EnglandH H Webster, T Nyberg, M A Sinnathamby, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Biochimica Et Biophysica Acta|April 14, 1976
Isolation, characterization and partial sequence of cyanogen bromide fragments and thiol peptides from pig kidney D-amino-acid oxidaseS Ronchi, L Minchiotti, B Curti, et al.
Journal of Clinical Microbiology|January 1, 1978
Production of human lymphoblastoid interferon by Namalva cellsK C Zoon, C E Buckler, P J Bridgen, et al.
European Journal of Biochemistry|July 1, 1980
D-glyceraldehyde-3-phosphate dehydrogenase. Complete amino-acid sequence of the enzyme from Bacillus stearothermophilusJ E Walker, A F Carne, M J Runswick, et al.
Journal of Bacteriology|September 1, 1972
Amino Acid Sequence Around the Catalytic Site in Glyceraldehyde-3-Phosphate Dehydrogenase from Bacillus stearothermophilusJ Bridgen, J I Harris, P W McDonald, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1979
Purification and partial characterization of human lymphoblast interferonK C Zoon, M E Smith, P J Bridgen, et al.
Science (New York, N.Y.)|February 1, 1980
Amino terminal sequence of the major component of human lymphoblastoid interferonK C Zoon, M E Smith, P J Bridgen, et al.
The Journal of Biological Chemistry|October 10, 1977
Human lymphoblastoid interferon. Large scale production and partial purificationP J Bridgen, C B Anfinsen, L Corley, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1979
Large-scale production and concentration of human lymphoid interferonF Klein, R T Ricketts, W I Jones, et al.
Nature Communications|October 13, 2022
Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in EnglandH H Webster, T Nyberg, M A Sinnathamby, et al.
Pageof 3